Investing.com - Novo Nordisk (CSE:NOVOb) ADR reported on Wednesday third quarter earnings that beat analysts' forecasts and revenue that topped expectations.
Novo Nordisk ADR announced earnings per share of kr0.8203 on revenue of kr5.54B. Analysts polled by Investing.com anticipated EPS of kr0.7768 on revenue of kr5.4B.
Novo Nordisk ADR shares are up 34% from the beginning of the year and are trading at kr113.96 , down-from-52-week-high.They are outperforming the STOXX 600 which is up 20.41% from the start of the year.
Novo Nordisk ADR shares gained 3.55% in intra-day trade the report.
Novo Nordisk ADR follows other major Healthcare sector earnings this month
Novo Nordisk ADR's report follows an earnings beat by J&J on October 19, who reported EPS of kr2.6 on revenue of kr23.34B, compared to forecasts EPS of kr2.35 on revenue of kr23.64B.
Pfizer had beat expectations on Tuesday with third quarter EPS of kr1.34 on revenue of kr24.09B, compared to forecast for EPS of kr1.08 on revenue of kr22.56B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar